Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes
In this study, we comprehensively analyzed genetic variations in SARS-CoV-2, gaining insights into amino acid variations in ORF1ab and COVID-19 outcomes.PMID:33798758 | DOI:10.1016/j.meegid.2021.104831
Source: Infection, Genetics and Evolution - Category: Genetics & Stem Cells Authors: Canhui Cao Liang He Yuan Tian Yu Qin Haiyin Sun Wencheng Ding Lingli Gui Peng Wu Source Type: research
More News: Australia Health | Canada Health | Coronavirus | COVID-19 | Epidemiology | Genetics | Pandemics | Respiratory Medicine | SARS | Study | USA Health